News

FDA expected to expand COVID-19 booster eligibility for children ages 12 to 15

Approval of a COVID-19 booster for children ages 12 to 15 could come in the days to weeks ahead.
Alembic intros generic Bactroban

Alembic's generic Bactroban provides a treatment for secondarily infected traumatic skin lesions due to susceptible isolates of Staphylococcus aureus and Streptococcus pyogenes.
Novartis receives FDA OK for Leqvio

Novartis has obtained global rights to develop, manufacture and commercialize Leqvio under a license and collaboration agreement with Alnylam Pharmaceuticals.
CDC updates and shortens recommended isolation and quarantine period for COVID-19

The change is motivated by science showing that the majority of SARS-CoV-2 transmission occurs early in the course of illness.
IRI postpones 2022 Growth Summit

Amid the rise in COVID-19, IRI has postponed its Growth Summit until 2023.
ANI gets FDA OK for generic Mycobutin

Rifabutin capsules have a market value of approximately $16.6 million, according to IQVIA.
FDA gives EU authorization for Molnupiravir

Molnupiravir received emergency use authorization for mild-to-moderate COVID-19 in adults.
Hy-Vee debuts two websites with ship-to-home services

Hy-VeeDeals.com and ShopPetShip.com will bring Hy-Vee offerings to all 50 states.

Hershey’s previews Valentine’s Day, Easter launches